{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T03:47:44Z","timestamp":1775965664775,"version":"3.50.1"},"reference-count":33,"publisher":"American Animal Hospital Association","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>This study described the rate of vaccine reactions in a population of dogs receiving vaccines after diagnosis of primary immune-mediated hemolytic anemia (IMHA). A secondary objective was to describe the time elapsed between vaccination and initial diagnosis of IMHA. A medical record search identified cases meeting criteria for primary IMHA. Owners and referring veterinarians were surveyed regarding vaccination of the dog following diagnosis. Referring veterinarians were surveyed regarding vaccination prior to diagnosis of IMHA. A completed survey was returned in 44 cases. Twenty-two dogs received vaccinations after diagnosis, and 22 dogs did not. The median time elapsed between vaccination and initial diagnosis was 280 days. No dog was vaccinated within 30 days of diagnosis. Two of the following possible reactions were noted out of 22 dogs vaccinated: vomiting and urticarial eruption in a dog administered a rabies and canine distemper vaccine, and recurrent anemia in a dog administered a rabies vaccine. The rate of vaccine reactions was higher than previously reported, although the time period evaluated was longer than in previous studies. The relationship between initial vaccination and development of IMHA, and between vaccination and vaccine reaction, in this population is uncertain and may reflect coincidence or differences in susceptibility.<\/jats:p>","DOI":"10.5326\/jaaha-ms-6868","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T12:36:55Z","timestamp":1542199015000},"page":"29-34","source":"Crossref","is-referenced-by-count":6,"title":["Vaccination and Associated Adverse Events in Dogs Previously Treated for Primary Immune-Mediated Hemolytic Anemia"],"prefix":"10.5326","volume":"55","author":[{"given":"Alaina","family":"Moon","sequence":"first","affiliation":[{"name":"From the Department of Small Animal Internal Medicine, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, Oregon (A.M.); and Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado (J.V.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Veir","sequence":"additional","affiliation":[{"name":"From the Department of Small Animal Internal Medicine, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, Oregon (A.M.); and Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado (J.V.)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3280","reference":[{"issue":"3","key":"bib1","series-title":"J Am Anim Hosp Assoc","first-page":"211","article-title":"Vaccination protocols for dogs predisposed to vaccine reactions","volume":"37","author":"Dodds\n              WJ","year":"2001","unstructured":"Dodds\n              WJ\n            \n          . Vaccination protocols for dogs predisposed to vaccine reactions. J Am Anim Hosp Assoc2001;37(3):211\u20134."},{"issue":"10","key":"bib2","series-title":"Rheumatology (Oxford)","first-page":"1815","article-title":"Vaccinations in patients with immune-mediated inflammatory diseases","volume":"49","author":"Rahier\n              JF","year":"2010","unstructured":"Rahier\n              JF\n            , MoutschenM, Van GompelA, et al. Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford)2010;49(10):1815\u201327."},{"issue":"9","key":"bib3","series-title":"Rheumatology (Oxford)","first-page":"1664","article-title":"Immunogenicity and impact on disease activity of influenza and pneumococcal vaccines in systemic lupus erythematosus: a systematic literature review and meta-analysis","volume":"55","author":"Pug\u00e8s\n              M","year":"2016","unstructured":"Pug\u00e8s\n              M\n            , BiscayP, BarnetcheT, et al. Immunogenicity and impact on disease activity of influenza and pneumococcal vaccines in systemic lupus erythematosus: a systematic literature review and meta-analysis. Rheumatology (Oxford)2016;55(9):1664\u201372."},{"issue":"3","key":"bib4","series-title":"Nat Rev Rheumatol","first-page":"135","article-title":"Vaccination of patients with autoimmune inflammatory rheumatic diseases","volume":"11","author":"Westra\n              J","year":"2015","unstructured":"Westra\n              J\n            , RondaanC, van AssenS, et al. Vaccination of patients with autoimmune inflammatory rheumatic diseases. Nat Rev Rheumatol2015;11(3):135\u201345."},{"key":"bib5","series-title":"EBioMedicine","first-page":"143","article-title":"Acetylcholine receptor antibody titers and clinical course after influenza vaccination in patients with myasthenia gravis: a double-blind randomized controlled trial (propatient-trial)","volume":"28","author":"Tackenberg\n              B","year":"2018","unstructured":"Tackenberg\n              B\n            , SchneiderM, BlaesF, et al. Acetylcholine receptor antibody titers and clinical course after influenza vaccination in patients with myasthenia gravis: a double-blind randomized controlled trial (propatient-trial). EBioMedicine2018;28:143\u201350."},{"issue":"5","key":"bib6","series-title":"Nephrology (Carlton)","first-page":"343","article-title":"Randomized trial investigating the safety and efficacy of influenza vaccination in patients with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"20","author":"Jeffs\n              LS","year":"2015","unstructured":"Jeffs\n              LS\n            , PehCA, JoseMD, et al. Randomized trial investigating the safety and efficacy of influenza vaccination in patients with antineutrophil cytoplasmic antibody-associated vasculitis. Nephrology (Carlton)2015;20(5):343\u201351."},{"key":"bib7","series-title":"Veterinary Immunology","first-page":"270","article-title":"The use of vaccines","author":"Tizard\n              IR","year":"2009","unstructured":"Tizard\n              IR\n            \n          . The use of vaccines. In: Veterinary Immunology. 8 ed.St. Louis: Elsevier; 2009:270\u201385."},{"issue":"30","key":"bib8","series-title":"Vaccine","first-page":"3876","article-title":"Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines","volume":"23","author":"Schattner\n              A","year":"2005","unstructured":"Schattner\n              A\n            \n          . Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine2005;23(30):3876\u201386."},{"key":"bib9","series-title":"Vet Clin North Am Small Anim Pract","first-page":"393","article-title":"Adverse vaccinal events in dogs and cats","volume":"40","author":"Moore\n              GE","year":"2010","unstructured":"Moore\n              GE\n            , HogenEschH. Adverse vaccinal events in dogs and cats. Vet Clin North Am Small Anim Pract2010;40:393\u2013407."},{"issue":"5","key":"bib10","series-title":"J Vet Intern Med","first-page":"290","article-title":"Vaccine-associated immune-mediated hemolytic anemia in the dog","volume":"10","author":"Duval\n              D","year":"1996","unstructured":"Duval\n              D\n            , GigerU. Vaccine-associated immune-mediated hemolytic anemia in the dog. J Vet Intern Med1996;10(5):290\u20135."},{"issue":"6","key":"bib11","series-title":"J Vet Intern Med","first-page":"504","article-title":"Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: a retrospective study of 72 dogs","volume":"16","author":"Carr\n              AP","year":"2002","unstructured":"Carr\n              AP\n            , PancieraDL, KiddL. Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: a retrospective study of 72 dogs. J Vet Intern Med2002;16(6):504\u20139."},{"issue":"5","key":"bib12","series-title":"J Am Anim Hosp Assoc","first-page":"384","article-title":"Immune-mediated hemolytic anemia: 70 cases (1988-1996)","volume":"35","author":"Reimer\n              ME","year":"1999","unstructured":"Reimer\n              ME\n            , TroyGC, WarnickLD. Immune-mediated hemolytic anemia: 70 cases (1988-1996). J Am Anim Hosp Assoc1999;35(5):384\u201391."},{"issue":"4","key":"bib13","series-title":"J Vet Intern Med","first-page":"456","article-title":"Treatment of immune-mediated hemolytic anemia in dogs with cyclophosphamide","volume":"14","author":"Burgess\n              K","year":"2000","unstructured":"Burgess\n              K\n            , MooreA, RandW, et al. Treatment of immune-mediated hemolytic anemia in dogs with cyclophosphamide. J Vet Intern Med2000;14(4):456\u201362."},{"issue":"11","key":"bib14","series-title":"J Am Vet Med Assoc","first-page":"1217","article-title":"Thrombocytopenia associated with vaccination of a dog with a modified-live paramyxovirus vaccine","volume":"186","author":"McAnulty\n              JF","year":"1985","unstructured":"McAnulty\n              JF\n            , RuddRG. Thrombocytopenia associated with vaccination of a dog with a modified-live paramyxovirus vaccine. J Am Vet Med Assoc1985;186(11):1217\u20139."},{"issue":"8","key":"bib15","series-title":"Am J Vet Res","first-page":"1269","article-title":"Canine distemper virus-induced thrombocytopenia","volume":"48","author":"Axthelm\n              MK","year":"1987","unstructured":"Axthelm\n              MK\n            , KrakowkaS. Canine distemper virus-induced thrombocytopenia. Am J Vet Res1987;48(8):1269\u201375."},{"issue":"1","key":"bib16","series-title":"Vet Comp Orthop Traumatol","first-page":"6","article-title":"Polyarthritis following vaccination in four dogs","volume":"16","author":"Kohn\n              B","year":"2003","unstructured":"Kohn\n              B\n            , GarnerM, LubkeS, et al. Polyarthritis following vaccination in four dogs. Vet Comp Orthop Traumatol2003;16(1):6\u201310."},{"issue":"10","key":"bib17","series-title":"J Am Vet Med Assoc","first-page":"1174","article-title":"Focal cutaneous vasculitis and alopecia at sites of rabies vaccination in dogs","volume":"188","author":"Wilcock\n              BP","year":"1986","unstructured":"Wilcock\n              BP\n            , YagerJA. Focal cutaneous vasculitis and alopecia at sites of rabies vaccination in dogs. J Am Vet Med Assoc1986;188(10):1174\u20137."},{"issue":"2","key":"bib18","series-title":"Vet Dermatol","first-page":"131","article-title":"Vaccine-induced ischemic dermatopathy in the dog","volume":"10","author":"Vitale\n              CB","year":"1999","unstructured":"Vitale\n              CB\n            , GrossTL, MagroCM. Vaccine-induced ischemic dermatopathy in the dog. Vet Dermatol1999;10(2):131\u201342."},{"issue":"1","key":"bib19","series-title":"J Vet Intern Med","first-page":"142","article-title":"Idiopathic immune-mediated thrombocytopenia and recent vaccination in dogs","volume":"26","author":"Huang\n              AA","year":"2012","unstructured":"Huang\n              AA\n            , MooreGE, Scott-MoncrieffJC. Idiopathic immune-mediated thrombocytopenia and recent vaccination in dogs. J Vet Intern Med2012;26(1):142\u20138."},{"issue":"4","key":"bib20","series-title":"J Vet Intern Med","first-page":"1467","article-title":"Evaluation of the risk of relapse of canine immune-mediated thrombocytopenia after routine vaccination","volume":"30","author":"Ellis\n              J","year":"2016","unstructured":"Ellis\n              J\n            , WardPM, FoaleRD. Evaluation of the risk of relapse of canine immune-mediated thrombocytopenia after routine vaccination. J Vet Intern Med2016;30(4):1467."},{"issue":"10","key":"bib21","series-title":"Vaccine","first-page":"1838","article-title":"NOPHO ITP working group and five national study groups. Vaccination associated thrombocytopenic purpura in children","volume":"25","author":"Rajantie\n              J","year":"2007","unstructured":"Rajantie\n              J\n            , ZellerB, TreutigerI, et al.; NOPHO ITP working group and five national study groups. Vaccination associated thrombocytopenic purpura in children. Vaccine2007;25(10):1838\u201340."},{"issue":"5","key":"bib22","series-title":"Vet Rec","first-page":"126","article-title":"Veterinary Products Committee working group report on feline and canine vaccination","volume":"150","author":"Gaskell\n              RM","year":"2002","unstructured":"Gaskell\n              RM\n            , GettinbyG, GrahamSJ, et al. Veterinary Products Committee working group report on feline and canine vaccination. Vet Rec2002;150(5):126\u201334."},{"issue":"7","key":"bib23","series-title":"J Am Vet Med Assoc","first-page":"1102","article-title":"Adverse events diagnosed within three days of vaccine administration in dogs","volume":"227","author":"Moore\n              GE","year":"2005","unstructured":"Moore\n              GE\n            , GuptillLF, WardMP, et al. Adverse events diagnosed within three days of vaccine administration in dogs. J Am Vet Med Assoc2005;227(7):1102\u20138."},{"key":"bib24","series-title":"Kirk\u2019s Current Veterinary Therapy","first-page":"275","article-title":"Management of immune-mediated hemolytic anemia in dogs","author":"Johnson\n              V","year":"2014","unstructured":"Johnson\n              V\n            , DowS. Management of immune-mediated hemolytic anemia in dogs. In: BonaguraJD, TwedtDC, eds. Kirk\u2019s Current Veterinary Therapy. 15 ed.St. Louis: Elsevier; 2014:275\u20139."},{"issue":"6","key":"bib25","series-title":"J Vet Intern Med","first-page":"1603","article-title":"Predicting outcome in dogs with primary immune-mediated hemolytic anemia: results of a multicenter case registry","volume":"29","author":"Goggs\n              R","year":"2015","unstructured":"Goggs\n              R\n            , DennisSG, Di BellaA, et al. Predicting outcome in dogs with primary immune-mediated hemolytic anemia: results of a multicenter case registry. J Vet Intern Med2015;29(6):1603\u201310."},{"issue":"3","key":"bib26","series-title":"Vet J","first-page":"347","article-title":"Serial assessment of the coagulation status of dogs with immune-mediated haemolytic anaemia using thromboelastography","volume":"191","author":"Goggs\n              R","year":"2012","unstructured":"Goggs\n              R\n            , WiinbergB, Kjelgaard-HansenM, et al. Serial assessment of the coagulation status of dogs with immune-mediated haemolytic anaemia using thromboelastography. Vet J2012;191(3):347\u201353."},{"issue":"1","key":"bib27","series-title":"Vet Microbiol","first-page":"51","article-title":"Vaccine side effects: fact and fiction","volume":"117","author":"Day\n              MJ","year":"2006","unstructured":"Day\n              MJ\n            \n          . Vaccine side effects: fact and fiction. Vet Microbiol2006;117(1):51\u20138."},{"issue":"3","key":"bib28","series-title":"Nat Rev Immunol","first-page":"169","article-title":"Discovering susceptibility genes for asthma and allergy","volume":"8","author":"Vercelli\n              D","year":"2008","unstructured":"Vercelli\n              D\n            \n          . Discovering susceptibility genes for asthma and allergy. Nat Rev Immunol2008;8(3):169\u201382."},{"issue":"2","key":"bib29","series-title":"Vet Dermatol","first-page":"95","article-title":"Review: Role of genetics and the environment in the pathogenesis of canine atopic dermatitis","volume":"26","author":"Bizikova\n              P","year":"2015","unstructured":"Bizikova\n              P\n            , Pucheu-HastonCM, EisenschenkMN, et al. Review: Role of genetics and the environment in the pathogenesis of canine atopic dermatitis. Vet Dermatol2015;26(2):95\u2013e26."},{"issue":"1","key":"bib30","series-title":"Tissue Antigens","first-page":"30","article-title":"Association of Doberman hepatitis to canine major histocompatibility complex II","volume":"77","author":"Dyggve\n              H","year":"2011","unstructured":"Dyggve\n              H\n            , KennedyLJ, MeriS, et al. Association of Doberman hepatitis to canine major histocompatibility complex II. Tissue Antigens2011;77(1):30\u20135."},{"issue":"8","key":"bib31","series-title":"Immunogenetics","first-page":"557","article-title":"MHC class II polymorphism is associated with a canine SLE-related disease complex","volume":"61","author":"Wilbe\n              M","year":"2009","unstructured":"Wilbe\n              M\n            , JokinenP, HermanrudC, et al. MHC class II polymorphism is associated with a canine SLE-related disease complex. Immunogenetics2009;61(8):557\u201364."},{"key":"bib32","series-title":"J Vet Intern Med","first-page":"366","article-title":"Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs","volume":"22","author":"Piek\n              CJ","year":"2008","unstructured":"Piek\n              CJ\n            , JuniusG, DekkerA, et al. Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs. J Vet Intern Med2008;22:366\u201373."},{"issue":"11","key":"bib33","series-title":"J Am Vet Med Assoc","first-page":"1869","article-title":"Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002)","volume":"226","author":"Weinkle\n              TK","year":"2005","unstructured":"Weinkle\n              TK\n            , CenterSA, RandolphJF, WarnerKL, BarrSC, ErbHN. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002). J Am Vet Med Assoc2005;226(11):1869\u201380."}],"container-title":["Journal of the American Animal Hospital Association"],"original-title":[],"link":[{"URL":"https:\/\/jaaha.kglmeridian.com\/view\/journals\/aaha\/55\/1\/article-p29.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jaaha\/article-pdf\/55\/1\/29\/2377179\/jaaha-ms-6868.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jaaha.kglmeridian.com\/downloadpdf\/journals\/aaha\/55\/1\/article-p29.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jaaha.kglmeridian.com\/downloadpdf\/journals\/aaha\/55\/1\/article-p29.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T16:03:01Z","timestamp":1763740981000},"score":1,"resource":{"primary":{"URL":"https:\/\/jaaha.kglmeridian.com\/view\/journals\/aaha\/55\/1\/article-p29.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":33,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.5326\/jaaha-ms-6868","relation":{},"ISSN":["0587-2871","1547-3317"],"issn-type":[{"value":"0587-2871","type":"print"},{"value":"1547-3317","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}